PL3651749T3 - Sposób leczenia urazowego uszkodzenia mózgu - Google Patents
Sposób leczenia urazowego uszkodzenia mózguInfo
- Publication number
- PL3651749T3 PL3651749T3 PL17743406.5T PL17743406T PL3651749T3 PL 3651749 T3 PL3651749 T3 PL 3651749T3 PL 17743406 T PL17743406 T PL 17743406T PL 3651749 T3 PL3651749 T3 PL 3651749T3
- Authority
- PL
- Poland
- Prior art keywords
- brain injury
- traumatic brain
- treating traumatic
- treating
- injury
- Prior art date
Links
- 208000030886 Traumatic Brain injury Diseases 0.000 title 1
- 230000009529 traumatic brain injury Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2017/050467 WO2019013615A1 (en) | 2017-07-12 | 2017-07-12 | METHOD OF TREATING TRAUMATIC BRAIN INJURY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3651749T3 true PL3651749T3 (pl) | 2025-01-27 |
Family
ID=59399463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17743406.5T PL3651749T3 (pl) | 2017-07-12 | 2017-07-12 | Sposób leczenia urazowego uszkodzenia mózgu |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200261488A1 (pl) |
| EP (1) | EP3651749B1 (pl) |
| CN (1) | CN110869010A (pl) |
| AU (1) | AU2017423466B2 (pl) |
| BR (1) | BR112020000602A2 (pl) |
| ES (1) | ES2995536T3 (pl) |
| PL (1) | PL3651749T3 (pl) |
| WO (1) | WO2019013615A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019013616A1 (en) | 2017-07-12 | 2019-01-17 | N.V. Nutricia | TREATMENT OF TRAUMATIC BRAIN INJURY |
| CN113679835A (zh) * | 2021-09-16 | 2021-11-23 | 四川力量科技有限公司 | 一种脑卒中后遗症康复用产品及其制备方法 |
| EP4401580A1 (en) | 2021-09-17 | 2024-07-24 | N.V. Nutricia | Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases |
| CN119522095A (zh) | 2022-07-01 | 2025-02-25 | N·V·努特里奇亚 | 用于神经退行性病变和神经创伤的营养组合物 |
| WO2025003349A1 (en) | 2023-06-30 | 2025-01-02 | N.V. Nutricia | Nutritional composition for neurodegeneration and neurotrauma |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012125020A1 (en) * | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Method for treating neurotrauma |
| CN103371993A (zh) | 2012-04-27 | 2013-10-30 | 复旦大学 | n-3不饱和脂肪酸在制备防治创伤性脑损伤药物中的用途 |
| US20140256813A1 (en) * | 2013-03-08 | 2014-09-11 | Nordic Naturals, Inc. | Methods for the treatment of brain injury using omega-3 fatty acids |
| WO2015115885A1 (en) * | 2014-01-31 | 2015-08-06 | N.V. Nutricia | Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly |
-
2017
- 2017-07-12 PL PL17743406.5T patent/PL3651749T3/pl unknown
- 2017-07-12 BR BR112020000602-5A patent/BR112020000602A2/pt not_active Application Discontinuation
- 2017-07-12 EP EP17743406.5A patent/EP3651749B1/en active Active
- 2017-07-12 AU AU2017423466A patent/AU2017423466B2/en active Active
- 2017-07-12 ES ES17743406T patent/ES2995536T3/es active Active
- 2017-07-12 CN CN201780093033.7A patent/CN110869010A/zh active Pending
- 2017-07-12 WO PCT/NL2017/050467 patent/WO2019013615A1/en not_active Ceased
-
2020
- 2020-01-10 US US16/739,663 patent/US20200261488A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017423466A1 (en) | 2019-01-17 |
| CN110869010A (zh) | 2020-03-06 |
| ES2995536T3 (en) | 2025-02-10 |
| AU2017423466A2 (en) | 2020-02-27 |
| BR112020000602A2 (pt) | 2020-07-14 |
| US20200261488A1 (en) | 2020-08-20 |
| EP3651749C0 (en) | 2024-09-04 |
| EP3651749B1 (en) | 2024-09-04 |
| EP3651749A1 (en) | 2020-05-20 |
| WO2019013615A1 (en) | 2019-01-17 |
| AU2017423466B2 (en) | 2024-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267934A (en) | Glyceryl 3-hydroxybururates Traumatic brain injury | |
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| ZA201705673B (en) | Methods for treating skin | |
| ZA201706616B (en) | Method for treating cancer | |
| IL257691A (en) | A method for treating cancer | |
| IL293712A (en) | Methods for treating mild brain injury | |
| ZA201706035B (en) | Method of treating a brain tumor | |
| IL280128A (en) | A method for treating epilepsy | |
| IL251262A0 (en) | Methods for treating traumatic brain injury | |
| GB2567616B (en) | Treatment method | |
| ZA202001880B (en) | Compositions and methods for treating brain injury | |
| IL267199A (en) | A method for treating epilepsy | |
| IL258988A (en) | Methods for treating epilepsy | |
| ZA202001141B (en) | Zeolite after treatment method | |
| IL255506A (en) | A method for treating a neurological disease | |
| IL276577A (en) | Methods for treating cardiac injury | |
| PL3651749T3 (pl) | Sposób leczenia urazowego uszkodzenia mózgu | |
| GB2571601B (en) | Treatment method | |
| IL250658A0 (en) | Methods for treating mild brain injury | |
| SG11202001806TA (en) | Treatment method | |
| EP3615013C0 (en) | THIOL COMPOUNDS FOR TREATING ACUTE TRAUMATIC BRAIN INJURY | |
| PT3426237T (pt) | Método para tratar atrofia cerebral | |
| HUE068710T2 (hu) | NK1-antagonista kombináció és eljárás szinukleinopátia kezelésére | |
| SG10201508795XA (en) | Method for treating cancer | |
| EP3703730A4 (en) | METHODS OF TREATMENT OF TRAUMATIC BRAIN LESIONS |